AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Leteva 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

VIVO Life Science

Salt Composition

Letrozole (2.5mg)

Overview Leteva 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letena 2.5mg tablets. This medication can be a standalone treatment or used alongside surgery or radiation therapy. In advanced cases, it helps prevent cancer metastasis. Letena 2.5mg tablets can be ingested with or without food, always following the physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to the individual's needs and determined by the treating physician to manage symptoms effectively. Continuous use is crucial as directed. Common side effects include increased perspiration, weariness, hot flashes, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as interactions may impact Letena's efficacy. Pregnant or breastfeeding patients should also disclose this information. Your doctor might order blood tests to assess vitamin D levels and bone density before and throughout the treatment course.

Uses of Leteva 2.5mg Tablet

Managing breast cancer

Major Benefits of Leteva 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Leteva 2.5mg Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Leteva 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Leteva 2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Leteva 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.

How Leteva 2.5mg Tablet works:

Leteva 2.5mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concomitant use of alcohol and Leteva 2.5mg Tablet.

PregnancyPregnancyUNSAFE

The use of Leteva 2.5mg Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animal and human subjects reveals substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Administering Leteva 2.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking a Leteva 2.5mg tablet can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Leteva 2.5mg tablets are considered safe for patients with kidney impairment; no dosage modification is typically needed. Data on its use in individuals with end-stage renal disease is, however, scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Leteva 2.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Leteva 2.5mg Tablet :

Should you forget a Leteva 2.5mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Leteva 2.5mg Tablet

LabelValue
Chemical Classification Diphenylmethane-based compound
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Leteva 2.5mg Tablet

Leteva 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Leteva 2.5mg tablets are anti-estrogen medications. They work by inhibiting aromatase, the enzyme that produces estrogen, thereby lowering estrogen levels. This is beneficial because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen levels can help prevent cancer growth.
For advanced breast cancer or cancer that has spread, continue Leteva 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Leteva 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Leteva 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Leteva 2.5mg Tablet can be taken together, closely monitor your blood pressure as Leteva may raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Leteva 2.5mg tablets may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Leteva 2.5mg Tablet may cause hot flushes, a common side effect resulting from decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment and subside afterward. If hot flushes are bothersome, consult your doctor for relief.
Leteva 2.5mg Tablet's serious side effects—stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions—are rare.
Leteva 2.5mg Tablets can reduce bone density (osteoporosis) due to lowered estrogen. Your doctor may monitor your bone density through testing before, during, and after treatment.
The Ministry of Health and Family Welfare restricts Leteva 2.5mg Tablets to the induction of ovulation in women with anovulatory infertility.
Leteva 2.5mg Tablet
194